Trials / Completed
CompletedNCT01350440
Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- University of South Florida · Academic / Other
- Sex
- All
- Age
- 10 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This is a preliminary study to determine the safety and efficacy of intravenous immune globulin in treating Spinocerebellar Ataxia. The investigators aim to assess changes in clinical measures of disease severity before and after treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | IVIG | Intravenous Immune Globulin |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2011-05-09
- Last updated
- 2013-07-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01350440. Inclusion in this directory is not an endorsement.